Trial intelligence / Profile preview

Doxepin buccal film in chronic insomnia

CTR20220868Phase 2Completed

Sponsor
Lipin Pharmaceutical
Start
Apr 2022
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of doxepin in Insomnia, sponsored by Lipin Pharmaceutical. Started Apr 2022; status: completed.

02

Drugs

doxepin
03

Conditions

Insomnia

Beyond the preview

Go deeper on CTR20220868.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20220868.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call